Skip to main content

WPI 3630 (Hydromorphone Hydrochloride Extended-Release 16 mg)

Pill with imprint WPI 3630 is Yellow, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 16 mg. It is supplied by Watson Laboratories, Inc.

Hydromorphone is used in the treatment of chronic pain; pain; anesthetic adjunct; cough and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 16 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3630

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.